Skip to main content
Erschienen in: European Surgery 6/2012

01.12.2012 | Original Article

The early results of intragastric balloon application of different BMI groups

verfasst von: Dr. S. Bozkurt, M.D., Assoc. Prof. H. Coskun, M.D.

Erschienen in: European Surgery | Ausgabe 6/2012

Einloggen, um Zugang zu erhalten

Summary

Aim

The aim of this study is to evaluate the weight loss effect of intragastric balloon (IB) application in patients with different body mass indexes (BMI) in the treatment of obesity.

Methods

Between 2005 and 2010, out of 251 obese patients treated with liquid-filled IB in our center, 220 obese patients in whom the balloons were removed after 180 days, aged 15–64 years and mean BMI 38.73 kg/m2 (27.01–77.16) were evaluated. The data of patients [weight, BMI, excess weight loss percentage (EWL%) and excess BMI loss percentage (EBMIL%) changes] at the day of insertion, at the day of removal and at sixth month of the removal were compared, according to their BMI indexes.

Results

The weight changes and BMIs of the patients had significantly decreased at the removal and at sixth month after the removal compared to the beginning (p < 0.01). However, the raise in the weights and BMIs at sixth month after the removal are also statistically significant (p < 0.01). The total weight losses, EWL% and EBMIL% according to BMI index groups are significantly decreased at removal compared to the beginning (p < 0.01). This significance is more prominent for patients with BMI 27–35 kg/m2.

Conclusions

IB can be used alone for patients with BMI < 35 kg/m2 to overcome obesity as a successful single stage procedure. However, for patients with BMI > 35 kg/m2 IB application should be combined with a surgical bariatric procedure to achieve a sustainable weight loss.
Literatur
1.
Zurück zum Zitat Deitel M. Overweight and obesity worldwide now estimated to involve 1.7 billion people. Obes Surg. 2003;13:329–30. PMID:12852397 doi:10.1381/096089203765887598.PubMedCrossRef Deitel M. Overweight and obesity worldwide now estimated to involve 1.7 billion people. Obes Surg. 2003;13:329–30. PMID:12852397 doi:10.1381/096089203765887598.PubMedCrossRef
2.
Zurück zum Zitat Mazure RA, Salgado G, Villareal P, Cobo B, Valencia A, Culebras JM. Intragastric balloon and multidisciplinary team. Nutr Hosp. 2009;24:282–7. PMID:19721900PubMed Mazure RA, Salgado G, Villareal P, Cobo B, Valencia A, Culebras JM. Intragastric balloon and multidisciplinary team. Nutr Hosp. 2009;24:282–7. PMID:19721900PubMed
3.
Zurück zum Zitat Buchwald H. Consensus Conference Statement Bariatric surgery for morbid obesity: health implications for patients, health professionals, and third-party payers. J Am Coll Surg. 2005;200:593–604. PMID:16925250 doi:10.1016/j.soard.2005.04.002. Buchwald H. Consensus Conference Statement Bariatric surgery for morbid obesity: health implications for patients, health professionals, and third-party payers. J Am Coll Surg. 2005;200:593–604. PMID:16925250 doi:10.1016/j.soard.2005.04.002.
4.
Zurück zum Zitat Fried M, Hainer V, Basdevant A, et al. Interdisciplinary European guidelines for surgery for severe (morbid) obesity. Obes Surg. 2007;17:260–70. PMID:17476884 doi:10.1007/s11695-007-9025-2.PubMedCrossRef Fried M, Hainer V, Basdevant A, et al. Interdisciplinary European guidelines for surgery for severe (morbid) obesity. Obes Surg. 2007;17:260–70. PMID:17476884 doi:10.1007/s11695-007-9025-2.PubMedCrossRef
5.
Zurück zum Zitat Carvalho GL, Barros CB, Okazaki M, et al. An improved intragastric balloon procedure using a new balloon: preliminary analysis of safety and efficacy. Obes Surg. 2009;19:237–42. PMID:18581191 doi:10.1007/s11695-008-9592-x.PubMedCrossRef Carvalho GL, Barros CB, Okazaki M, et al. An improved intragastric balloon procedure using a new balloon: preliminary analysis of safety and efficacy. Obes Surg. 2009;19:237–42. PMID:18581191 doi:10.1007/s11695-008-9592-x.PubMedCrossRef
6.
Zurück zum Zitat Coskun H, Aksakal C. Experience with sedation technique for intragastric balloon placement and removal. Obes Surg. 2007;17:995–6. PMID:17894166 doi:10.1007/s11695-007-9158-3.PubMedCrossRef Coskun H, Aksakal C. Experience with sedation technique for intragastric balloon placement and removal. Obes Surg. 2007;17:995–6. PMID:17894166 doi:10.1007/s11695-007-9158-3.PubMedCrossRef
7.
Zurück zum Zitat Coskun H, Bozkurt S. A case of asymptomatic fungal and bacterial colonization of an intragastric balloon. World J Gastroenterol. 2009;15:5751–3. PMID:19960576 doi:10.3748/wjg.15.5751.PubMedCrossRef Coskun H, Bozkurt S. A case of asymptomatic fungal and bacterial colonization of an intragastric balloon. World J Gastroenterol. 2009;15:5751–3. PMID:19960576 doi:10.3748/wjg.15.5751.PubMedCrossRef
8.
Zurück zum Zitat Imaz I, Martinez-Cervell C, Garcia-Alvarez EE, Sendra-Gutierrez JM, Gonzalez-Enriquez J. Safety and effectiveness of the intragastric balloon for obesity. A meta-analysis. Obes Surg. 2008;18:841–6. PMID:18459025 doi:10.1007/s11695-007-9331-8.PubMedCrossRef Imaz I, Martinez-Cervell C, Garcia-Alvarez EE, Sendra-Gutierrez JM, Gonzalez-Enriquez J. Safety and effectiveness of the intragastric balloon for obesity. A meta-analysis. Obes Surg. 2008;18:841–6. PMID:18459025 doi:10.1007/s11695-007-9331-8.PubMedCrossRef
9.
Zurück zum Zitat De Waele B, Reynaert H, Urbain D, Willems G. Intragastric balloons for preoperative weight reduction. Obes Surg. 2000;10:58–60. PMID:10715647 doi:10.1381/09608920060674139.PubMedCrossRef De Waele B, Reynaert H, Urbain D, Willems G. Intragastric balloons for preoperative weight reduction. Obes Surg. 2000;10:58–60. PMID:10715647 doi:10.1381/09608920060674139.PubMedCrossRef
10.
Zurück zum Zitat Genco A, Cipriano M, Materia A, et al. Laparoscopic sleeve gastrectomy versus intragastric balloon: a case-control study. Surg Endosc. 2009;23:1849–53. PMID:19169745 doi:10.1007/s00464-008-0285-2.PubMedCrossRef Genco A, Cipriano M, Materia A, et al. Laparoscopic sleeve gastrectomy versus intragastric balloon: a case-control study. Surg Endosc. 2009;23:1849–53. PMID:19169745 doi:10.1007/s00464-008-0285-2.PubMedCrossRef
11.
Zurück zum Zitat Herve J, Wahlen CH, Schaeken A, et al. What becomes of patients one year after the intragastric balloon has been removed? Obes Surg. 2005;15:864–70. PMID:15978160 doi:10.1381/0960892054222894.PubMedCrossRef Herve J, Wahlen CH, Schaeken A, et al. What becomes of patients one year after the intragastric balloon has been removed? Obes Surg. 2005;15:864–70. PMID:15978160 doi:10.1381/0960892054222894.PubMedCrossRef
12.
Zurück zum Zitat Weiner R, Gutberlet H, Bockhorn H. Preparation of extremely obese patients for laparoscopic gastric banding by gastric-balloon therapy. Obes Surg. 1999;9:261–4. PMID:10484312 doi:10.1381/096089299765553133.PubMedCrossRef Weiner R, Gutberlet H, Bockhorn H. Preparation of extremely obese patients for laparoscopic gastric banding by gastric-balloon therapy. Obes Surg. 1999;9:261–4. PMID:10484312 doi:10.1381/096089299765553133.PubMedCrossRef
13.
Zurück zum Zitat Forlano R, Ippolito AM, Iacobellis A, et al. Effect of the BioEnterics intragastric balloon on weight, insulin resistance, and liver steatosis in obese patients. Gastrointest Endosc. 2010;71:927–33 PMID:19863955 doi:10.1016/j.gie.2009.06.036.PubMedCrossRef Forlano R, Ippolito AM, Iacobellis A, et al. Effect of the BioEnterics intragastric balloon on weight, insulin resistance, and liver steatosis in obese patients. Gastrointest Endosc. 2010;71:927–33 PMID:19863955 doi:10.1016/j.gie.2009.06.036.PubMedCrossRef
14.
Zurück zum Zitat Crea N, Pata G, Della Casa D, et al. Improvement of metabolic syndrome following intragastric balloon: 1 year follow-up analysis. Obes Surg. 2009;19:1084–8. PMID:19506981 doi:10.1007/s11695-009-9879-6.PubMedCrossRef Crea N, Pata G, Della Casa D, et al. Improvement of metabolic syndrome following intragastric balloon: 1 year follow-up analysis. Obes Surg. 2009;19:1084–8. PMID:19506981 doi:10.1007/s11695-009-9879-6.PubMedCrossRef
15.
Zurück zum Zitat Ricci G, Bersani G, Rossi A, Pigo F, De Fabritiis G, Alvisi V. Bariatric therapy with intragastric balloon improves liver dysfunction and insulin resistance in obese patients. Obes Surg. 2008;18:1438–42. PMID:18369681 doi:10.1007/s11695–008-9487-x.PubMedCrossRef Ricci G, Bersani G, Rossi A, Pigo F, De Fabritiis G, Alvisi V. Bariatric therapy with intragastric balloon improves liver dysfunction and insulin resistance in obese patients. Obes Surg. 2008;18:1438–42. PMID:18369681 doi:10.1007/s11695–008-9487-x.PubMedCrossRef
16.
Zurück zum Zitat Mui WL, Ng EK, Tsung BY, Lam CH, Yung MY. Impact on obesity-related illnesses and quality of life following intragastric balloon. Obes Surg. 2010;20:1128–32. PMID:19015930 doi:10.1007/s11695-008-9766-6.PubMedCrossRef Mui WL, Ng EK, Tsung BY, Lam CH, Yung MY. Impact on obesity-related illnesses and quality of life following intragastric balloon. Obes Surg. 2010;20:1128–32. PMID:19015930 doi:10.1007/s11695-008-9766-6.PubMedCrossRef
Metadaten
Titel
The early results of intragastric balloon application of different BMI groups
verfasst von
Dr. S. Bozkurt, M.D.
Assoc. Prof. H. Coskun, M.D.
Publikationsdatum
01.12.2012
Verlag
Springer Vienna
Erschienen in
European Surgery / Ausgabe 6/2012
Print ISSN: 1682-8631
Elektronische ISSN: 1682-4016
DOI
https://doi.org/10.1007/s10353-012-0167-7

Weitere Artikel der Ausgabe 6/2012

European Surgery 6/2012 Zur Ausgabe